Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: web + 0.22  Related to the article below (Last Update: 8/4/2008)

Salix Pharmaceuticals Reports 2Q2008 Results
FOXBusiness -
Interested parties can access the conference call by way of web cast or telephone. The live web cast will be available at www.salix.com. A replay of the web ...SLXP
athenahealth, Inc. Reports Second Quarter 2008 Results
WELT ONLINE, Germany -
A live webcast and replay will also be available shortly after the call is completed on the Company's investor web site: ...ATHN
Lydall Announces Financial Results for the Second Quarter and Six ...
CNNMoney.com -
The call may be accessed in a listen-only mode at 877-440-5804 and will be webcast live on the Company's web site www.lydall.com under the Investor ...LDL
Altra Holdings Announces Record Financial Results for the Second ...
MarketWatch -
Also, the company has posted slides on its web site at http://www.altramotion.com in the Investor Relations Section in the Events & Presentations tab to ...AIMC

Earthtimes (press release)
Watts Water Technologies Reports Second Quarter 2008 Results
WELT ONLINE, Germany - Jul 29, 2008
Watts Water Technologies, Inc. will hold a live web cast of its conference call to discuss second quarter results for 2008 on Tuesday, July 29, 2008, ...
GFI Group Inc. Announces Second Quarter 2008 Results; Declares ... MarketWatch
The Phoenix Companies, Inc. Second Quarter 2008 Earnings StreetInsider.com (subscription)
TTM Technologies, Inc. Reports Second Quarter 2008 Results Trading Markets (press release)
WELT ONLINE
all 1,378 news articles »  GFIG - UNM - PNX
K-Swiss Inc. Reports Second Quarter Results
MarketWatch - Jul 31, 2008
The Company will also provide an online Web simulcast and rebroadcast of this conference call. The live broadcast of K-Swiss' quarterly conference call will ...KSWS
Online Resources Posts Second Quarter 2008 Results
WELT ONLINE, Germany - Jul 29, 2008
Online Resources Corporation (Nasdaq:ORCC), a leading provider of web-based financial services, today reported financial and operating results for the three ...ORCC
Firefox 3 chipping away Safari market share, summer browsing ...
TG Daily - Aug 1, 2008
... of users were browsing the web using an iPhone. Following June 11, when the iPhone 3G was introduced, that share increased to 0.22% (recorded yesterday).
Tasty Baking Company Reports Second Quarter 2008 Results
MarketWatch - Aug 1, 2008
Investors will have the opportunity to listen to the call over the Internet at Tasty Baking Company's web site, http://www.tastykake.com. ...TSTY
digital newspapers
CNET News, CA - Jul 10, 2008
Kodak also claims a sub-0.22 second shot lag ("click to capture"). The Z1015 IS will ship in September for $349.95. As for the other model, the M1093 IS is ...
Source: Google News

[PS] WebSIFT: The Web Site Information Filter System -
R Cooley, PN Tan, J Srivastava - Proceedings of the Web Usage Analysis and User Profiling …, 1999 - cs.umn.edu
... from the University of Minnesota Department of Computer Science and Engineering
Web site; http ... The supports of these itemsets are 0.25% and 0.22% respectively. ...

Reliability of Web-based teledermatology consultations -
MO Oztas, E Calikoglu, K Baz, A Birol, M Onder, T … - Journal of Telemedicine and Telecare, 2004 - ingentaconnect.com
... 0.22?0.32). Seventy-seven per cent of the patients were correctly diagnosed by at
least two dermatologists when clinical information was provided. A Web- ...

Friends and neighbors on the Web -
LA Adamic, E Adar - Social Networks, 2003 - Elsevier
... For the Stanford social web C is 0.22 while for MIT it is 0.21, both 70 times greater
than for random graphs with the same number of nodes and edges. ...

Secretion capture and report web: use of affinity derivatized agarose microdroplets for the … -
F Gray, JS Kenney, JF Dunne - Journal of Immunological Methods, 1995 - Elsevier
... viable hybridoma cells using a secretion capture and reporter web (SCRW). ... brief boiling
in a microwave, filter-sterilized by passage through 0.22 pm disposable ...

Measuring the Independence of Central Banks and Its Effect on Policy Outcomes -
A Cukierman, SB Web, B Neyapti - The World Bank Economic Review, 1992 - World Bank
... Legal central bank in- depen- dence" (index) 0.33 0.33 0.31 0.30 0.30 0.30 0.29
0.29 0.27 0.27 0.27 0.27 0.25 0.24 0.24 0.22 0.21 0.21 0.21 0.20 0.20 0.18 0.17 ...

[PDF] Removal policies in network caches for world-wide web documents -
S Williams, M Abrams, CR Strandridge, G Abdulla, E … - Computer Communication Review, 1996 - cs.kent.edu
... caching in networks with workloads like ours could dramat- ically reduce the load
on popular Web servers. ... CGI 0.13 0.08 0.15 0.12 0.12 0.03 0.22 0.00 0.95 0.05 ...
-

Regulation of Lake Primary Productivity by Food Web Structure -
SR Carpenter, JF Kitchell, JR Hodgson, PA Cochran, … - Ecology, 1987 - JSTOR
... of these interannual differences in weather, as well as the dynamics of an undisturbed
food web. ... trap-1. h-1) 0 0 0 0 0.94 (0.22) 0 Bass (fish/ha) YOY --* 242 ...

Variation in d 15 N and d 13 C trophic fractionation: implications for aquatic food web studies -
MJ Vander Zanden, JB Rasmussen - Limnology and Oceanography, 2001 - JSTOR
... 0.22* 0.70 N= 15 8 13 5 Mean (+1 SE) 3.49 ... A literature review produced 35 A8'5N
estimates and 42 A^'3C estimates from 22 studies and 20 species (Web Appendix 1 ...

[PDF] IVOA Web Services Basic Profile Version 0.22 IVOA Working Draft 2005 September 30
A Schaaff - ivoa.net
... 5 7. Toward a VO Web Service Basic Profile.....5 ... 6 8.3
VO Support Interfaces 0.22 conformance [10 ...

[CITATION] Results 1-10 of about 30 for related: www. wpi. edu/Pubs/ETD/Avai...(0.22 seconds) An error occurred …
MP Firms, P Switching

Source: Google Scholar
 
 

Scientists Develop A New Way To Target Alzheimer's Disease

Article Date: 07 Dec 2006 - 13:00pm (PST)
The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins.

Researchers hope to slow or even prevent the development of Alzheimer's by reducing or preventing the aggregation of amyloid beta. These deposits are one of the defining characteristics of Alzheimer's disease. Although scientists still aren't sure whether plaques are the initial trigger for the disease or are a consequence of it, the clumps can appear years before the onset of clinical symptoms. By the time dementia emerges, the plaques litter the brain.

In a new animal study, the NYU School of Medicine researchers report that they have reduced by around 50 percent the aggregation of toxic amyloid protein in the brains of mice by blocking the interaction between a protein called apolipoprotein E (apo E) and amyloid. Apo E acts as a sort of biological chaperone, ferrying cholesterol and fats around the brain.

Article continues below and (thank you)
 
The researchers, led by Martin Sadowski, M.D., Ph.D., Assistant Professor of Neurology and Psychiatry and Dr. Thomas Wisniewski, M.D., Professor of Neurology, Pathology and Psychiatry, created a nontoxic, synthetic protein fragment or peptide that binds to apo E, preventing it from latching onto amyloid. Deprived of its biochemical chaperone, amyloid won't form deadly plaques.

In a series of studies in transgenic mice, the peptide reduced the amount of plaque in the brain and the amount of amyloid in the brain's blood vessels. It did not cause any apparent inflammation or leaks in blood vessels in the animals' brains, according to the study. Finally, in another set of experiments, the treated mice did not exhibit any memory decline when they were put into a radial arm maze, which evaluates working memory based on the animals' behavior. The peptide, which crosses the blood-brain barrier, was injected into the animals' abdomens.

It is the first time apo E has been manipulated in this way, according to Dr. Wisniewski. The study is published in the December 5, 2006, issue of the Proceedings of the National Academy of Sciences.

"Our approach opens up a completely new avenue for therapy," says Dr. Wisniewski. "There is a lot of data showing that apo E is important in sporadic Alzheimer's disease. But until now no one has really addressed how you can manipulate its interaction with amyloid beta." Alzheimer's affects some 4.6 million people in the United States, and the devastating neurodegenerative disease occurs most commonly as "sporadic," meaning it affects individuals who do not have rare genetic mutations.

Amyloid beta is a shape-changing chameleon. It normally exists as a nontoxic linear chain of amino acids. But the protein becomes a killer of neurons when it transforms itself into a spiral-like form that aggregates into plaques in the brain.

Apo E is a key player in the deadly transformation of amyloid. Dr. Wisniewski, who is among the scientists who first described the role of apo E in amyloid deposition, describes the lipoprotein as a "pathological chaperone." A string of amino acids on amyloid beta binds to apo E, and this deadly embrace triggers the transformation of amyloid. The NYU researchers stitched together the string of amino acids on amyloid beta to create their synthetic peptide "mimic."

In a recent review article in the journal Science, scientists enumerated several approaches that are being pursued to reduce amyloid in the brain. One of the most promising is to inhibit an enzyme that shears off amyloid beta from a larger protein. However, this enzyme plays a variety of roles in the body, and concerns have arisen about the deleterious systemic affects of inhibiting it. Concerns also have emerged about vaccines to amyloid beta, and a clinical trial of one vaccine had to be halted because 6 percent of patients developed brain inflammation. In addition, studies in Alzheimer animal models and in the few vaccinated individuals who have had autopsies have suggested that vaccination can produce bleeding in the brain.

The NYU researchers said they were encouraged that their synthetic peptide did not appear to cause inflammation or bleeding in the brains of the animals tested. "In order for a peptide like this to be used in humans it would have to be taken for many years, much like statin medications for cholesterol," said Dr. Sadowski, whose research has been supported by a Paul B. Beeson Career Development in Aging a grant jointly funded by the American Federation of Aging Research and the National Institute on Aging. "Our ongoing research is now focusing on transforming the peptide used in the study into an agent that could be used clinically. It would have to be taken for a very long period of time without causing toxicity."

###

Contact: Jennifer Choi
New York University Medical Center and School of Medicine
 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News4 ; News5 ; News6 ; News7 ; News8 ; News9 ; Nedws9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 
 © 2002-2006

Keywords::

Contact Iconocast

Home Page